Scholarship INC.

Livestock Improvement: How Forward Pack and Sexed Semen Can Boost Genetic Gain |  MarketScreener

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model | MarketScreener

Myriad’s MyRisk™ hereditary cancer test with RiskScore® provides personalized breast cancer risk assessment for women of all backgrounds SALT LAKE CITY, 08 Dec. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a well-calibrated and more …

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model | MarketScreener Read More »

Livestock Improvement: How Forward Pack and Sexed Semen Can Boost Genetic Gain |  MarketScreener

This planet is drying up. And these are the consequences | MarketScreener

Drought is one of the “most destructive” natural disasters in terms of loss of life, resulting from impacts such as large-scale crop failures, forest fires and water stress. In other words, droughts are one of the “world’s most feared natural phenomena”; they devastate farmland, destroy livelihoods and cause untold suffering, as reported by the world’s …

This planet is drying up. And these are the consequences | MarketScreener Read More »

Livestock Improvement: How Forward Pack and Sexed Semen Can Boost Genetic Gain |  MarketScreener

Fulgent Genetics, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline November 21, 2022 in Securities Fraud Class Action | MarketScreener

RADNOR, Pa., November 18, 2022 /PRNewswire/ — The law firm Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) advises investors that a class action securities lawsuit has been filed against Fulgent Genetics, Inc. (“Fulgent” ) (NASDAQ: FLGT). The suit accuses Fulgent of violations of federal securities laws, including omissions and fraudulent misrepresentations regarding the company’s business, …

Fulgent Genetics, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline November 21, 2022 in Securities Fraud Class Action | MarketScreener Read More »

GeneSight mental health monitor reveals gap in frontline mental health care |  MarketScreener

GeneSight mental health monitor reveals gap in frontline mental health care | MarketScreener

Survey finds primary care providers want patients to raise mental health issues so they can provide better overall care SALT LAKE CITY, Nov. 17, 2022 (GLOBE NEWSWIRE) — Over 83% of primary care providers (PCPs) want more of their patients to talk to them about mental health issues and concerns so they can provide better …

GeneSight mental health monitor reveals gap in frontline mental health care | MarketScreener Read More »

GeneSight mental health monitor reveals gap in frontline mental health care |  MarketScreener

GeneSight mental health monitor reveals gap in frontline mental health care | MarketScreener

SALT LAKE CITY, November 17, 2022 (GLOBE NEWSWIRE) — More than 83% of primary care providers (PCPs) want more of their patients to talk to them about mental health issues and concerns so they can provide better overall care, according to the latest GeneSight® Mental Health Monitor, a national survey A myriad of genetics, Inc. …

GeneSight mental health monitor reveals gap in frontline mental health care | MarketScreener Read More »